AFJK

Aimei Health Technology Co., Ltd. operates as a healthcare services provider in China, specializing in aesthetic medical treatments and wellness services. Headquartered in Guangzhou, the company operates a network of medical aesthetic clinics and healthcare facilities across multiple Chinese cities, delivering services including cosmetic surgery, dermatology treatments, anti-aging therapies, and preventive healthcare solutions. The company's business model combines direct-to-consumer clinic operations with technology-enabled service platforms that connect patients with medical professionals. AFJK generates revenue through treatment fees, membership programs, and sales of proprietary skincare products developed in-house. The company positions itself in China's rapidly expanding medical aesthetics market, which has experienced significant growth driven by rising disposable incomes and increasing consumer acceptance of cosmetic procedures among younger demographics. Recent developments include the expansion of its clinic footprint into tier-two cities and investments in digital health platforms to enhance customer engagement and appointment scheduling. The company emphasizes standardized treatment protocols across its facilities and employs licensed medical practitioners specialized in aesthetic procedures. AFJK competes with both established hospital-based aesthetic departments and independent clinic chains, differentiating itself through brand recognition and integrated service offerings that span surgical and non-surgical aesthetic treatments alongside general wellness services.